There are 807 resources available
357P - Molecular stratification of small cell lung carcinoma subtypes by immunoexpression of ASCL1, NEUROD1, POU2F3 and YAP1 with clinicopathological correlation
Presenter: Sunil Pasricha
Session: Poster viewing 05.
358P - Intracranial metastatic disease (IMD) burden and management of patients with small cell lung cancer (SCLC): A population-based analysis of 8705 patients
Presenter: Karolina Gaebe
Session: Poster viewing 05.
359P - Epidermal growth factor receptor (EGFR) mutation testing and immunotherapy (IO) use associated with diagnosis of non-small cell lung cancer (NSCLC) with EGFR exon 20 insertions (ex20ins) in the US
Presenter: Sai-Hong Ou
Session: Poster viewing 05.
360P - ELIOS: A multicentre, molecular profiling study of patients (pts) with epidermal growth factor receptor-mutated (EGFRm) advanced NSCLC treated with first-line (1L) osimertinib
Presenter: Zofia Piotrowska
Session: Poster viewing 05.
361P - 8-year long term survival status in a phase III randomized study in EGFR mutated advanced lung cancer patients in the first-line
Presenter: Ajaykumar Singh
Session: Poster viewing 05.
362P - Intracranial activity of dacomitinib in treatment naïve advanced EGFR mutated non-small cell lung cancer (NSCLC): Prespecified subgroup analysis of the ATORG-003 trial
Presenter: Aaron Tan
Session: Poster viewing 05.
364P - Tepotinib with an EGFR-tyrosine kinase inhibitor (TKI) in patients with EGFR-mutant MET-amplified NSCLC: A case series
Presenter: Azura Ahmad
Session: Poster viewing 05.
365P - Patterns of progression on first-line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study
Presenter: Alexandra Schuler
Session: Poster viewing 05.
366P - EGFR amplification is a putative resistance mechanism for NSCLC-LM patients with TKI therapy and is associated with poor outcome
Presenter: Hainan Yang
Session: Poster viewing 05.